Bright Minds Biosciences (DRUG) Earnings (2019 - 2026)
Bright Minds Biosciences (DRUG) earnings from Dec 31, 2019 to Mar 31, 2026. The TTM Bright Minds Biosciences (DRUG) earnings is -$20M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Bright Minds Biosciences (DRUG) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +725.16% |
| 3 Years TTM | +38.84% |
| 5 Years TTM | +56.54% |
| All Time TTM | +81.64% |
Annual Earnings change of Bright Minds Biosciences (DRUG)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$7.64M | -13.05% |
| 2025 | -$8.79M | +324.36% |
| 2024 | -$2.07M | -61.86% |
| 2023 | -$5.43M | -49.83% |
| 2022 | -$11M | +61.00% |
| 2021 | -$6.72M | +1726.59% |
| 2020 | -$368K | +102.97% |
| 2019 | -$181K | N/A |
Comparison Bright Minds Biosciences (DRUG) five years earnings CAGR with competitors
Bright Minds Biosciences (DRUG) five years earnings CAGR is 56.50%.